Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
出版年份 2015 全文链接
标题
Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
作者
关键词
TAZ, EGFR, EMT, Gefitinib, Lung adenocarcinoma
出版物
Cell and Bioscience
Volume 5, Issue 1, Pages 7
出版商
Springer Nature
发表日期
2015-06-18
DOI
10.1186/2045-3701-5-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells
- (2014) Hsiao-Chi Tsai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
- (2014) Y. Zhao et al. CANCER RESEARCH
- An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non-Small Cell Lung Cancer
- (2014) S. Noguchi et al. CLINICAL CANCER RESEARCH
- Tyrosine Phosphoproteomics Identifies Both Codrivers and Cotargeting Strategies for T790M-Related EGFR-TKI Resistance in Non-Small Cell Lung Cancer
- (2014) T. Yoshida et al. CLINICAL CANCER RESEARCH
- Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis
- (2014) A. N. Lau et al. EMBO JOURNAL
- Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53
- (2013) Nan Bai et al. CANCER BIOLOGY & THERAPY
- Emerging roles of TEAD transcription factors and its coactivators in cancers
- (2013) Ajaybabu V. Pobbati et al. CANCER BIOLOGY & THERAPY
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma
- (2013) B Mao et al. ONCOGENE
- Tumour suppressor genes in chemotherapeutic drug response
- (2012) Dulcie Lai et al. BIOSCIENCE REPORTS
- Role of TAZ as Mediator of Wnt Signaling
- (2012) Luca Azzolin et al. CELL
- TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin
- (2012) Nuo Yang et al. CELL CYCLE
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer
- (2012) Mian Xie et al. Journal of Thoracic Oncology
- The EGFR T790M Mutation in Acquired Resistance to an Irreversible Second-Generation EGFR Inhibitor
- (2012) Y. Kim et al. MOLECULAR CANCER THERAPEUTICS
- Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
- (2012) Zhenfeng Zhang et al. NATURE GENETICS
- YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14
- (2012) J-M Huang et al. ONCOGENE
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
- (2011) Michelangelo Cordenonsi et al. CELL
- Role of YAP/TAZ in mechanotransduction
- (2011) Sirio Dupont et al. NATURE
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- TAZ is a novel oncogene in non-small cell lung cancer
- (2011) Z Zhou et al. ONCOGENE
- Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
- (2010) C. A. Hall et al. CANCER RESEARCH
- EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
- (2010) Kenichi Suda et al. Journal of Thoracic Oncology
- Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs
- (2010) Jin-Haeng Chung et al. LUNG CANCER
- Transcriptional Coactivator with PDZ-binding Motif Is Essential for Normal Alveolarization in Mice
- (2009) Akihisa Mitani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Connective Tissue Growth Factor Confers Drug Resistance in Breast Cancer through Concomitant Up-regulation of Bcl-xL and cIAP1
- (2009) M.-Y. Wang et al. CANCER RESEARCH
- TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition
- (2009) Heng Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
- (2008) Q.-Y. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
- (2008) C.-H. Yun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started